Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibandronate for Bone Loss Prevention After Renal Transplantation
NCT00423384Phase 3Unknown
- Sponsor
- Smerud Medical Research
- Start
- Jan 2007
- Primary completion
- Dec 2009
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibandronate in osteoporosis, sponsored by Smerud Medical Research. Primary endpoint: Difference in percent lumbar Bone Mineral Density change at 12 months. Status: unknown.
02
Drugs
ibandronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00423384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423384.